The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.

MLA

Pedroza-Roldán, César, et al. “The BCGΔBCG1419c Strain, Which Produces More Pellicle in Vitro, Improves Control of Chronic Tuberculosis in Vivo.” Vaccine, vol. 34, no. 40, Sept. 2016, pp. 4763–70. EBSCOhost, https://doi.org/10.1016/j.vaccine.2016.08.035.

APA

Pedroza-Roldán, C., Guapillo, C., Barrios-Payán, J., Mata-Espinosa, D., Aceves-Sánchez, M. de J., Marquina-Castillo, B., Hernández-Pando, R., & Flores-Valdez, M. A. (2016). The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo. Vaccine, 34(40), 4763–4770. https://doi.org/10.1016/j.vaccine.2016.08.035

Chicago

Pedroza-Roldán, César, Carolina Guapillo, Jorge Barrios-Payán, Dulce Mata-Espinosa, Michel de Jesús Aceves-Sánchez, Brenda Marquina-Castillo, Rogelio Hernández-Pando, and Mario Alberto Flores-Valdez. 2016. “The BCGΔBCG1419c Strain, Which Produces More Pellicle in Vitro, Improves Control of Chronic Tuberculosis in Vivo.” Vaccine 34 (40): 4763–70. doi:10.1016/j.vaccine.2016.08.035.